Management of high blood pressure in children

similarities and differences between US and European guidelines

Tammy McLoughlin Brady, Amalia Stefani-Glücksberg, Giacomo D. Simonetti

Research output: Contribution to journalArticle

Abstract

Over the last several decades, many seminal longitudinal cohort studies have clearly shown that the antecedents to adult disease have their origins in childhood. Hypertension (HTN), which has become increasingly prevalent in childhood, represents one of the most important risk factors for cardiovascular diseases (CVD) such as heart disease and stroke. With the risk of adult HTN much greater when HTN is manifest in childhood, the future burden of CVD worldwide is therefore concerning. In an effort to slow the current trajectory, professional societies have called for more rigorous, evidence-based guideline development to aid primary care providers and subspecialists in improving recognition, diagnosis, evaluation, and treatment of pediatric HTN. In 2016 the European Society of Hypertension and in 2017 the American Academy of Pediatrics published updated guidelines for prevention and management of high blood pressure (BP) in children. While there are many similarities between the two guidelines, important differences exist. These differences, along with the identified knowledge gaps in each, will hopefully spur clinical researchers to action. This review highlights some of these similarities and differences, focusing on several of the more important facets regarding prevalence, prevention, diagnosis, management, and treatment of childhood HTN.

Original languageEnglish (US)
Pages (from-to)1-8
Number of pages8
JournalPediatric Nephrology
DOIs
StateAccepted/In press - Mar 28 2018

Fingerprint

Guidelines
Hypertension
Cardiovascular Diseases
Pediatrics
Longitudinal Studies
Heart Diseases
Primary Health Care
Cohort Studies
Stroke
Research Personnel
Therapeutics

Keywords

  • Adolescent
  • Cardiovascular disease
  • Childhood
  • Children
  • Clinical practice guideline
  • High blood pressure
  • Hypertension
  • Management
  • Prevalence

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Nephrology

Cite this

Management of high blood pressure in children : similarities and differences between US and European guidelines. / Brady, Tammy McLoughlin; Stefani-Glücksberg, Amalia; Simonetti, Giacomo D.

In: Pediatric Nephrology, 28.03.2018, p. 1-8.

Research output: Contribution to journalArticle

@article{c5a1e610b9e443dc9cea1b45518c48b0,
title = "Management of high blood pressure in children: similarities and differences between US and European guidelines",
abstract = "Over the last several decades, many seminal longitudinal cohort studies have clearly shown that the antecedents to adult disease have their origins in childhood. Hypertension (HTN), which has become increasingly prevalent in childhood, represents one of the most important risk factors for cardiovascular diseases (CVD) such as heart disease and stroke. With the risk of adult HTN much greater when HTN is manifest in childhood, the future burden of CVD worldwide is therefore concerning. In an effort to slow the current trajectory, professional societies have called for more rigorous, evidence-based guideline development to aid primary care providers and subspecialists in improving recognition, diagnosis, evaluation, and treatment of pediatric HTN. In 2016 the European Society of Hypertension and in 2017 the American Academy of Pediatrics published updated guidelines for prevention and management of high blood pressure (BP) in children. While there are many similarities between the two guidelines, important differences exist. These differences, along with the identified knowledge gaps in each, will hopefully spur clinical researchers to action. This review highlights some of these similarities and differences, focusing on several of the more important facets regarding prevalence, prevention, diagnosis, management, and treatment of childhood HTN.",
keywords = "Adolescent, Cardiovascular disease, Childhood, Children, Clinical practice guideline, High blood pressure, Hypertension, Management, Prevalence",
author = "Brady, {Tammy McLoughlin} and Amalia Stefani-Gl{\"u}cksberg and Simonetti, {Giacomo D.}",
year = "2018",
month = "3",
day = "28",
doi = "10.1007/s00467-018-3946-y",
language = "English (US)",
pages = "1--8",
journal = "Pediatric Nephrology",
issn = "0931-041X",
publisher = "Springer Verlag",

}

TY - JOUR

T1 - Management of high blood pressure in children

T2 - similarities and differences between US and European guidelines

AU - Brady, Tammy McLoughlin

AU - Stefani-Glücksberg, Amalia

AU - Simonetti, Giacomo D.

PY - 2018/3/28

Y1 - 2018/3/28

N2 - Over the last several decades, many seminal longitudinal cohort studies have clearly shown that the antecedents to adult disease have their origins in childhood. Hypertension (HTN), which has become increasingly prevalent in childhood, represents one of the most important risk factors for cardiovascular diseases (CVD) such as heart disease and stroke. With the risk of adult HTN much greater when HTN is manifest in childhood, the future burden of CVD worldwide is therefore concerning. In an effort to slow the current trajectory, professional societies have called for more rigorous, evidence-based guideline development to aid primary care providers and subspecialists in improving recognition, diagnosis, evaluation, and treatment of pediatric HTN. In 2016 the European Society of Hypertension and in 2017 the American Academy of Pediatrics published updated guidelines for prevention and management of high blood pressure (BP) in children. While there are many similarities between the two guidelines, important differences exist. These differences, along with the identified knowledge gaps in each, will hopefully spur clinical researchers to action. This review highlights some of these similarities and differences, focusing on several of the more important facets regarding prevalence, prevention, diagnosis, management, and treatment of childhood HTN.

AB - Over the last several decades, many seminal longitudinal cohort studies have clearly shown that the antecedents to adult disease have their origins in childhood. Hypertension (HTN), which has become increasingly prevalent in childhood, represents one of the most important risk factors for cardiovascular diseases (CVD) such as heart disease and stroke. With the risk of adult HTN much greater when HTN is manifest in childhood, the future burden of CVD worldwide is therefore concerning. In an effort to slow the current trajectory, professional societies have called for more rigorous, evidence-based guideline development to aid primary care providers and subspecialists in improving recognition, diagnosis, evaluation, and treatment of pediatric HTN. In 2016 the European Society of Hypertension and in 2017 the American Academy of Pediatrics published updated guidelines for prevention and management of high blood pressure (BP) in children. While there are many similarities between the two guidelines, important differences exist. These differences, along with the identified knowledge gaps in each, will hopefully spur clinical researchers to action. This review highlights some of these similarities and differences, focusing on several of the more important facets regarding prevalence, prevention, diagnosis, management, and treatment of childhood HTN.

KW - Adolescent

KW - Cardiovascular disease

KW - Childhood

KW - Children

KW - Clinical practice guideline

KW - High blood pressure

KW - Hypertension

KW - Management

KW - Prevalence

UR - http://www.scopus.com/inward/record.url?scp=85044468552&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85044468552&partnerID=8YFLogxK

U2 - 10.1007/s00467-018-3946-y

DO - 10.1007/s00467-018-3946-y

M3 - Article

SP - 1

EP - 8

JO - Pediatric Nephrology

JF - Pediatric Nephrology

SN - 0931-041X

ER -